3-(4-(4-(4-(5-oxo-1,6-naphthyridin-6(5H)-yl)phenyl)piperazin-1-yl)butyl)-1H-indole-5-carbonitrile

ID: ALA4867414

PubChem CID: 118190855

Max Phase: Preclinical

Molecular Formula: C31H30N6O

Molecular Weight: 502.62

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  N#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc(-n5ccc6ncccc6c5=O)cc4)CC3)c2c1

Standard InChI:  InChI=1S/C31H30N6O/c32-21-23-6-11-29-28(20-23)24(22-34-29)4-1-2-14-35-16-18-36(19-17-35)25-7-9-26(10-8-25)37-15-12-30-27(31(37)38)5-3-13-33-30/h3,5-13,15,20,22,34H,1-2,4,14,16-19H2

Standard InChI Key:  FGYLPIJGSRWQAL-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 38 43  0  0  0  0  0  0  0  0999 V2000
    6.7638  -20.4207    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.5410  -20.6754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0212  -20.0121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5410  -19.3530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7118  -18.5546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1053  -18.0068    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3281  -18.2573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1573  -19.0557    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7638  -19.6035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2761  -17.2084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4427  -16.4059    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.8384  -20.0121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2470  -19.3072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0641  -19.3072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4727  -18.5981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2899  -18.5981    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.6985  -19.3072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5157  -19.3072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9243  -18.5981    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.5157  -17.8890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6985  -17.8890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7415  -18.5981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1501  -19.3072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9673  -19.3072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3759  -18.5981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9673  -17.8890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1501  -17.8890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6447  -18.5981    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.0533  -17.8890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6447  -17.1840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8275  -17.1840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4189  -17.8890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6017  -17.8890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1931  -18.5981    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.6017  -19.3072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4189  -19.3072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8275  -18.5981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1931  -17.1840    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  1  9  1  0
  4  9  2  0
 10 11  3  0
  6 10  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 16 21  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 22 27  2  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  2  0
 36 37  1  0
 28 37  1  0
 32 37  2  0
 33 38  2  0
 25 34  1  0
 19 22  1  0
 15 16  1  0
  3 12  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4867414

   3-(4-(4-(4-(5-oxo-1,6-naphthyridin-6(5H)-yl)phenyl)piperazin-1-yl)butyl)-1H-indole-5-carbonitrile

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 502.62

Molecular Weight (Monoisotopic): 502.2481

AlogP: 4.88

#Rotatable Bonds: 7

Polar Surface Area: 80.95

Molecular Species: BASE

HBA: 6

HBD: 1

#RO5 Violations: 1

HBA (Lipinski): 7

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 1

CX Acidic pKa: ┄

CX Basic pKa: 8.59

CX LogP: 5.03

CX LogD: 3.82

Aromatic Rings: 5

Heavy Atoms: 38

QED Weighted: 0.32

Np Likeness Score: -1.27

References

1. Xu T, Xue Y, Lu J, Jin C..  (2021)  Synthesis and biological evaluation of 1-(4-(piperazin-1-yl)phenyl)pyridin-2(1H)-one derivatives as potential SSRIs.,  223  [PMID:34182358] [10.1016/j.ejmech.2021.113644]

Source

Source(1):

• Scientific Literature